Form 8-K for ADVAXIS, INC.
Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Item 7.01 Regulation FD Disclosures.A copy of the press release of Advaxis, Inc. (the “Company”) dated January 8, 2016 relating to the announcement discussed in Item 8.01 below is attached hereto as Exhibit 99.1.The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 8.01 Other Events.On January 8, 2016, the Company issued a press release announcing its 2016 business outlook. The press release also outlined various regulatory, clinical, business and operational milestones for 2015.
Item 9.01. Financial Statements and Exhibits.(d) ExhibitsThe following exhibits are furnished as a part of this report:
Exhibit Number Description 99.1 Press Release dated January 8, 2016